A journey without a map: Lessons in building an oncology powerhouse where innovation thrives
What does it take to deliver the next generation of cancer therapies? And how to stay ahead in a field that’s constantly evolving?
These are the questions Astellas’ leaders have been answering during their decade-long journey to build an oncology powerhouse from the ground up. Today, oncology is the company’s largest therapy area of strategic focus and investment and the lessons learned are changing the face of innovation in oncology and beyond.
JOIN SOME OF THE KEY PLAYERS IN ASTELLAS’ ONCOLOGY JOURNEY TO DISCUSS:
- Unlocking the potential of patient-centered science
- Creating an environment where innovation thrives
- Accelerating development through strategic partnerships
- Applying learnings in oncology to breakthrough therapeutic areas
Click here for additional information and registration details.
Related Content
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
Clinical Trial Innovation: How Healthcare Technology is Evolving
Join us as we discuss how the healthcare landscape is changing in technology and clinical trial innovation, including diversity improvement, leveraging real-world evidence, comparative arms, and decentralized clinical trials.
Keeping pace with the evolving global landscape in vaccine development
Hear from a panel of Life Science experts on the latest advancements and innovative modalities paving the way in the global vaccine development space. What has been COVID-19's impact on drug development and the regulatory landscape? Key factors contributing to Asia Pacific being recognised as the hub for vaccine development and opportunities for biotech's to leverage. Key considerations for pre-clinical and clinical planning to accelerate vaccine development, supporting a robust global strategy.